Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

155
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
155
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive Optics RTX1 Imaging for Early Detection of Retinal Vascular Remodeling in Hypertensive Retinopathy: A Review.

Journal of clinical medicine·2026
Same author

"Eye-Conic" Spatial Transcriptomics Reveals the Layer-Specific Molecular Alterations in Corneas of Patients With Keratoconus.

Investigative ophthalmology & visual science·2026
Same author

CRISPR and Beyond: Genome-Editing Strategies in Retinal Stem Cell Research.

Cells·2026
Same author

Common and Distinct Features in Serum Proteomic Profiles in Keratoconus, Post-Laser Vision Correction Ectasia, and Pellucid Marginal Degeneration.

Investigative ophthalmology & visual science·2026
Same author

Current Trends in Presbyopia Correction-A Comprehensive Review.

Journal of clinical medicine·2026
Same author

Using Large Language Models for In Silico Development and Simulation of a Patient-Reported Outcome Questionnaire for Cataract Surgery with Various Intraocular Lenses: A Pre-Validation Study.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Mar 16, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

3.0K

Immunomodulation on the ocular surface: a review.

Anna M Ambroziak1, Jerzy Szaflik2, Jacek P Szaflik2

  • 1SPKSO Ophthalmic University Hospital, Warsaw, Poland; Information Optics Department, Faculty of Physics, University of Warsaw, Poland.

Central-European Journal of Immunology
|August 19, 2016
PubMed
Summary

This study explores the ocular surface as part of the mucosal immune system, offering new ways to treat dry eye disease. Novel therapies like cyclosporine A and autologous serum are discussed for managing ocular inflammation and improving tear film stability.

Keywords:
dry eye diseaseocular surfacetopical cyclosporintopical immunomodulation

More Related Videos

Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation
09:03

Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation

Published on: November 17, 2014

10.2K
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

10.9K

Related Experiment Videos

Last Updated: Mar 16, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

3.0K
Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation
09:03

Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation

Published on: November 17, 2014

10.2K
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

10.9K

Area of Science:

  • Immunology
  • Ophthalmology
  • Dry Eye Disease Research

Background:

  • The ocular surface is now recognized as a key component of the common mucosal immune system.
  • Understanding immune mechanisms on the ocular surface provides opportunities to manage inflammatory conditions.
  • Inflammation significantly impacts tear film stability and contributes to dry eye disease symptoms.

Purpose of the Study:

  • To provide an overview of ocular surface anatomy and physiology.
  • To explain the underlying immunological mechanisms of dry eye disease.
  • To discuss current and emerging treatment modalities for dry eye disease.

Main Methods:

  • Review of current literature on ocular surface immunology and dry eye disease.
  • Analysis of physiological and anatomical aspects of the ocular surface.
  • Discussion of therapeutic strategies including pharmacological and biological agents.

Main Results:

  • The ocular surface's role in the mucosal immune system offers therapeutic targets for dry eye.
  • Inflammation is a central factor in the pathophysiology of dry eye disease.
  • Several novel treatments show promise for managing ocular surface inflammation.

Conclusions:

  • A deeper understanding of ocular immunology is crucial for effective dry eye management.
  • Novel treatments like cyclosporine A, autologous serum, and growth factors represent promising therapeutic avenues.
  • Ongoing research into experimental treatments may offer future solutions for dry eye disease.